Sponsored by:
Unlock New Frontiers in ALS Research with iPSC-Derived Motor Neurons and Microglia
A Cutting-Edge Model for Neurodegenerative Disease Studies
Amyotrophic lateral sclerosis (ALS) is a devastating neurodegenerative disorder with no effective cure. Traditional models have struggled to fully capture the complexity of ALS, making innovative in vitro approaches essential for advancing research and therapeutic discovery.
Our latest white paper, iPSC-Derived Motor Neurons and Microglia: A Robust Model for ALS Research and Drug Discovery, explores how patient-derived iPSCs provide a breakthrough approach to studying ALS pathology at the cellular level.
Key Insights You'll Gain:
- How iPSC-derived motor neurons and microglia exhibit ALS-related disease phenotypes
- Functional analysis of neuronal activity, burst firing, and synchronicity using live-cell imaging
- The role of microglial phagocytosis in ALS progression and how it differs in patient-derived cells
- The power of iPSC models for drug screening and personalized medicine
This white paper provides essential data on how iPSC-based models can transform neurodegenerative disease research.
